What is MOBI's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.29B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for MOBI?

P/E (TTM) is n/a and 52-week range is $8.29 to $15.29 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s MOBI figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

Where is Mobia Medical Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Austin, Texas, US, 33.3M shares outstanding, ISIN US60705V1035 when available from company profile and filing metadata.

Chartloom

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Mobia Medical, Inc. operates as a commercial-stage medical device company. The company is headquartered in Austin, Texas and currently employs 167 full-time employees. The company went IPO on 2026-05-08. The Company’s Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the clinically validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The Vivistim System includes an implantable device that stimulates the vagus nerve only when intentionally activated, triggering the release of neuromodulators, including acetylcholine, norepinephrine, and serotonin. Its neuromodulators create a heightened state of plasticity in the brain, such that neural networks can more readily adapt and reform in response to stimuli. The implantable components of the Vivistim System-namely, the implantable pulse generator (IPG) and lead-are implanted through a minimally invasive outpatient procedure that takes approximately 60 minutes.

Employees

167

Website

www.mobia.com

IPO

2026-05-08

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)